Abstract

BackgroundThe aim of this analysis was to investigate the potential impact of Ki67 assay in a series of patients affected by early stage invasive lobular carcinoma (ILC) undergone surgery.MethodsClinical-pathological data were correlated with disease-free and overall survival (DFS/OS). The maximally selected Log-Rank statistics analysis was applied to the Ki67 continuous variable to estimate appropriate cut-offs. The Subpopulation Treatment Effect Pattern Plot (STEPP) analysis was performed to assess the interaction between ‘pure’ or ‘mixed’ histology ILC and Ki67.ResultsAt a median follow-up of 67 months, 10-years DFS and OS of 405 patients were 67.8 and 79.8 %, respectively. Standardized Log-Rank statistics identified 2 optimal cut-offs (6 and 21 %); 10-years DFS and OS were 75.1, 66.5, and 30.2 % (p = 0.01) and 84.3, 76.4 and 59 % (p = 0.003), for patients with a Ki67 < 6 %, between 6 and 21 %, and >21 %, respectively. Ki67 and lymph-node status were independent predictor for longer DFS and OS at the multivariate analysis, with radiotherapy (for DFS) and age (for OS). Ki67 highly replicated at the internal cross-validation analysis (DFS 85 %, OS 100 %). The STEPP analysis showed that DFS rate decreases as Ki67 increases and those patients with ‘pure’ ILC performed worse than ‘mixed’ histology.ConclusionsDespite the retrospective and exploratory nature of the study, Ki67 was able to significantly discriminate the prognosis of patients with ILC, and the effect was more pronounced for patients with ‘pure’ ILC.Electronic supplementary materialThe online version of this article (doi:10.1186/s13046-016-0325-z) contains supplementary material, which is available to authorized users.

Highlights

  • The aim of this analysis was to investigate the potential impact of Ki67 assay in a series of patients affected by early stage invasive lobular carcinoma (ILC) undergone surgery

  • The Subpopulation Treatment Effect Pattern Plot (STEPP) analysis was performed to assess the interaction between histological subtypes and Ki67; we aimed to evaluate whether the prognostic effect varies according to the Ki67 [22]

  • With regard to the adjuvant treatment, hormonotherapy was administered to 85.4 % of patients, while

Read more

Summary

Introduction

The aim of this analysis was to investigate the potential impact of Ki67 assay in a series of patients affected by early stage invasive lobular carcinoma (ILC) undergone surgery. Invasive lobular breast cancer differs from IDC for clinical outcome and recurrence pattern as well. It was historically considered a good prognostic subtype, given the more favorable pathological parameters (higher estrogen receptor [ER] expression, lower histological grade and lower mitotic index in comparison with IDC) [7, 8]. More recent findings suggest that, despite a trend towards slightly better short-term outcome, the overall prognosis for patients with ILC seems to be similar or worse than those with IDC, with a trend to progressively relapse more frequently at approximately 6 years after the diagnosis [1, 9, 10]

Objectives
Methods
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call